Pathological myocardial hypertrophy involves many signaling pathways, among which the most studied are the MAPK, NFAT, STAT, PKC, PI3K/PKB, NF-κB, and Wnt pathways [3, 21–23]. Here, NFKB1 is linked to cardiac hypertrophy.